23andMe Holding Co. (NASDAQ:ME) Q3 2022 Earnings Conference Call February 10, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder & Chief Executive Officer Steve Schoch - Chief Financial Officer Kenneth Hillan - Head of Therapeutics Conference Call Participants Tiago Fauth - Credit Suisse Daniel Grosslight - Citi Operator Good morning and welcome to 23andMe's Fiscal Year 2022 Third Quarter Financial Results Conference Call. As a reminder, this ca ...